O-RADS Ultrasound (Adnexal Lesion Risk Stratification)
ACR O-RADS US v2022Assigns an ACR O-RADS US (v2022) category 0-5 to an ovarian or adnexal lesion from its ultrasound descriptors, returning the associated malignancy risk band and management guidance.
Also searched as: adnexal mass · ovarian cyst · gynecology · ovarian · cyst
Information
Incomplete input
- The following information is still needed: technical adequacy of the examination.
How this tool works
The Ovarian-Adnexal Reporting and Data System for ultrasound standardizes how adnexal lesions are described and stratified. Lesions are first separated into normal/physiologic findings, classic benign lesions (paraovarian cyst, hydrosalpinx, peritoneal inclusion cyst, hemorrhagic cyst, dermoid, endometrioma), and all other lesions. Other lesions are scored by composition: cystic lesions without a solid component use locularity, inner wall/septation contour, size, menopausal status, and color Doppler score; cystic lesions with a solid component use locularity with either papillary-projection count (unilocular) or color score (septated); solid lesions use outer contour, broad/diffuse acoustic shadowing, and color score. Unexplained ascites upgrades O-RADS 3-4 lesions to O-RADS 5. Each category 0-5 carries a defined malignancy risk range (<1% up to >=50%) with linked management recommendations.
References
- Andreotti RF, Timmerman D, et al. O-RADS US v2022 (Radiology 2023)
- ACR O-RADS lexicon descriptors and definitions
- Radiopaedia — O-RADS ultrasound
Implemented from the cited published sources. Educational use only; confirm against current guidelines before clinical use.
Clinical questions that use this
Vetting guides that reach for this tool.
Related calculators
Same subspecialty, overlapping subject matter.